Vesalius Biocapital Partners and SRIW have led a €10m funding round in Belgian pharmaceuticals company Euroscreen.
Other investors in the round included Life Sciences Research Partners VZW, Societe de Participation et de Gestion, Hunza Ventures and existing shareholders Fortis Private Equity, Compagnie du Bois Sauvage,...
GP has held a final close short of its initial €800m target, following a challenging fundraise
Deal for luxury catering company marks the first investment by Livingbridge's sixth fund
RSK received £33m of debt funding from Permira Debt Managers in 2015
Clessidra reaped a 3x money return following a 17-month holding period